Literature DB >> 26473948

Epidermal growth factor (EGF) activates nuclear factor-κB through IκBα kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IκBα.

G Sethi, K S Ahn, M M Chaturvedi, B B Aggarwal.   

Abstract

Entities:  

Year:  2015        PMID： 26473948     DOI： 10.1038/onc.2015.313

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  3 in total

Review 1.  Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.

Authors:  Laura D'Ignazio; Michael Batie; Sonia Rocha
Journal:  Biomedicines       Date:  2017-05-09

2.  Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.

Authors:  Xuejiao Liu; Yiming Tu; Yifeng Wang; Di Zhou; Yulong Chong; Lin Shi; Guanzheng Liu; Xu Zhang; Sijin Wu; Huan Li; Shangfeng Gao; Mingshan Niu; Rutong Yu
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

3.  Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway.

Authors:  Jing Zhu; Ying Xin; Xiaoliang Liu; Ying Wang; Ying Liu
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.